Clinical Trial Update: Treatment of Uterine Fibroids With Asoprisnil(J867) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Asoprisnil (J867) for uterine fibroids, including related menorrhagia and metrorrhagia, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menorrhagia
• Metrorrhagia
• Uterine Leiomyoma

Drugs mentioned

• Asoprisnil (J867) (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Leiomyoma, Menorrhagia | Phase 3 | Status: COMPLETED